Agilent expands range of NMR and MRI products

First of the new products is the Direct Drive 2 (DD2) NMR/MRI console, which extends experimental capabilities in a robust and reliable package.

Among an array of new console features are new transmitter boards and phase shifters that enable finer control of phase, frequency and amplitude.

These features directly translate to improved waveform control and better experimental results.

Next is the VnmrJ 3.1 software, which introduces the concept of automated, sample-centric workflows that make it easy and intuitive to execute experiments and analyse data.

The new software package also comprises an expanded portfolio of experimental tools, including qNMR, DOSY and Fast Methods that enable researchers to easily quantify the constituents in a sample, analyse mixtures and ramp system throughput using optimised experimental sequences.

Third, Agilent has expanded the portfolio of OneNMR probes to include new versions at 500 and 600MHz with automated tuning capabilities.

This advanced technology platform enables researchers to utilise a single probe to perform experiments on multiple nuclei without switching probes.

Finally, the new narrow-bore HFXY probe utilises the same T3 technology found in the company's wide-bore HXFY MAS probe.

Suitable for complex solid-state NMR applications, the new design enables customers with narrow-bore magnets to access a wide range of experiments without the need for multiple probes.

These new products will be on display at the Experimental Nuclear Magnetic Resonance Conference, 10-15 April in Pacific Grove, California, US.

The American Chemical Society recently designated the development of the Varian A-60 NMR spectrometer, an instrument used by chemists for decades to perform chemical analysis, as a National Historic Chemical Landmark.

Agilent acquired Varian in May 2010, bringing together two Silicon Valley pioneers.